Organism name | Rhodiola sachalinensis |
---|---|
Genus | Rhodiola |
Family | Crassulaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Rhodiola sachalinensis |
---|---|
Linked NCBI taxonomy ID | 265354 |
Linked level | species |
Family in NCBI taxonomy | Crassulaceae |
---|---|
ID | 3781 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005347
![]() |
Rhodiosin
/ Herbacetin 7-glucosyl-(1->3)-rhamnoside |
CHEMBL596218
|
No. 1 | No. 15 |
![]() |
|||
C00005163
![]() |
Leucoside
/ Kaempferol 3-sambubioside / 5,7-Dihydroxy-2-(4-hydroxyphenyl)-3-[(2-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-4H-1-benzopyran-4-one |
CHEMBL446574
CHEMBL1096690 |
No. 1 | No. 15 |
![]() |
|||
C00005338
![]() |
Rhodionin
/ Herbacetin 7-rhamnoside / Herbacetin 7-O-alpha-L-rhamnopyranoside |
CHEMBL596258
|
No. 2 | No. 15 |
![]() |
|||
C00013329
![]() |
Tricin
/ 5,7,4'-Trihydroxy-3',5'-dimethoxyflavone / 5,7-Dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL454320
|
C017769
|
No. 3 | No. 15 |
![]() |
||
C00031262
![]() |
Sachaloside III
/ (-)-Sachaloside III |
No. 5 | No. 15 |
![]() |
||||
C00000960
![]() |
Eriodictyol
|
CHEMBL8996
CHEMBL307893 CHEMBL1975989 |
C007619
|
32 / 29 / 55 | 5 / 0 | No. 25 | No. 14 |
![]() |
C00031186
![]() |
Rosin
/ Rosin X / (-)-Rosin / trans-Cinnamyl beta-D-glucopyranoside |
No. 45 | No. 72 |
![]() |
||||
C00029468
![]() |
Phenethyl beta-D-glucopyranoside
/ 2-Phenylethyl beta-D-glucopyranoside / (-)-Phenethyl beta-D-glucopyranoside |
CHEMBL510617
CHEMBL1802183 |
No. 45 | No. 72 |
![]() |
|||
C00029812
![]() |
Benzyl beta-D-glucopyranoside
/ (-)-Benzyl-O-beta-D-glucopyranoside |
CHEMBL1170453
CHEMBL2336738 |
C410942
|
No. 45 | No. 72 |
![]() |
||
C00031274
![]() |
Salidroside
/ Rhodioloside / (-)-Rhodioloside / Tyrosol alpha-(beta-D-glucopyranoside) |
CHEMBL465208
CHEMBL1899113 |
C009172
|
3 / 0 / 0 | No. 45 | No. 72 |
![]() |
|
C00008818
![]() |
Epigallocatechin
/ (-)-Epigallocatechin |
CHEMBL47386
CHEMBL125743 CHEMBL130415 CHEMBL264167 CHEMBL404845 |
26 / 17 / 29 | No. 52 | No. 14 |
![]() |
||
C00000674
![]() |
Luteolin
|
CHEMBL151
|
D047311
|
99 / 91 / 95 | 76 / 6 | No. 71 | No. 15 |
![]() |
C00004565
![]() |
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 |
![]() |
C00031184
![]() |
Rosarin
|
No. 128 | No. 72 |
![]() |
||||
C00031185
![]() |
Rosavin
|
CHEMBL1083511
|
1 / 1 / 1 | No. 128 | No. 72 |
![]() |
||
C00030363
![]() |
Gein
/ Geoside |
No. 128 | No. 72 |
![]() |
||||
C00031260
![]() |
Sachaloside I
/ (-)-Sachaloside I |
No. 167 |
![]() |
|||||
C00031261
![]() |
Sachaloside II
/ (-)-Sachaloside II |
No. 167 |
![]() |
|||||
C00029424
![]() |
1-Octyl-beta-D-glucopyranoside
|
CHEMBL446037
CHEMBL1222151 CHEMBL1689637 CHEMBL2303841 |
C018619
|
No. 258 | No. 73 |
![]() |
||
C00031152
![]() |
Rhodiocyanoside A
|
No. 258 | No. 73 |
![]() |
||||
C00001448
![]() |
Lotaustralin
/ (R)-Lotaustralin |
C001556
|
No. 258 | No. 73 |
![]() |
|||
C00031263
![]() |
Sachaloside V
/ (-)-Sachaloside V |
No. 258 | No. 73 |
![]() |
||||
C00002933
![]() |
Pentagalloyl-beta-D-glucose
/ 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose / (+)-1,2,3,4,6-Penta-O-galloyl-beta-D-glucose |
CHEMBL127911
CHEMBL262173 CHEMBL206710 CHEMBL207164 CHEMBL382408 CHEMBL377052 CHEMBL425946 CHEMBL383306 CHEMBL207014 CHEMBL1224764 CHEMBL1500249 |
C013185
|
46 / 53 / 44 | 5 / 0 | No. 302 | No. 81 |
![]() |
C00002486
![]() |
Nodakenin
|
CHEMBL459825
|
C471579
|
11 / 8 / 6 | No. 399 | No. 25 |
![]() |
|
C00032577
![]() |
1,2,3,6-Tetra-O-galloyl-beta-D-glucose
|
CHEMBL449947
CHEMBL1159463 |
C060475
|
11 / 2 / 2 | No. 448 | No. 81 |
![]() |
|
C00031158
![]() |
Rhodioloside E
/ Sachaloside VIII / (-)-Sachaloside VIII |
No. 565 | No. 73 |
![]() |
||||
C00030606
![]() |
Kenposide A
/ (-)-Kenposide A / Geranyl beta-vicianoside |
C084878
|
No. 565 | No. 73 |
![]() |
|||
C00031188
![]() |
Rosiridoside B
/ (-)-Rosiridoside B |
No. 565 | No. 73 |
![]() |
||||
C00031264
![]() |
Sachaloside VI
/ (-)-Sachaloside VI |
No. 650 |
![]() |
|||||
C00031189
![]() |
Rosiridoside C
|
No. 650 |
![]() |
|||||
C00031265
![]() |
Sachaloside VII
/ (-)-Sachaloside VII |
No. 650 |
![]() |
|||||
C00029285
![]() |
Rosiridin
/ (-)-Rosiridol 1-O-beta-D-glucopyranoside |
No. 650 |
![]() |
|||||
C00002647
![]() |
Gallic acid
|
CHEMBL288114
|
D005707
|
42 / 53 / 68 | 52 / 16 | No. 817 | No. 81 |
![]() |
C00000152
![]() |
p-Coumaric acid
|
CHEMBL66879
CHEMBL2336752 |
C032171
|
23 / 13 / 18 | 6 / 1 | No. 904 | No. 6 |
![]() |
C00000580
![]() |
trans-p-Coumaric acid
/ trans-p-Hydroxycinnamic acid |
CHEMBL66879
CHEMBL2336752 |
23 / 13 / 18 | No. 904 | No. 6 |
![]() |
||
C00000615
![]() |
Caffeic acid
|
CHEMBL145
CHEMBL1320034 |
68 / 64 / 63 | No. 904 | No. 6 |
![]() |
||
C00029515
![]() |
p-Tyrosol
/ 4-(2-Hydroxyethyl)phenol / p-Hydroxyphenethyl alcohol / 2-(4-Hydroxyphenyl)ethanol |
CHEMBL53566
|
C011867
|
6 / 3 / 5 | No. 936 | No. 6 |
![]() |
|
C00032375
![]() |
(E)-Cinnamic alcohol
/ trans-Cinnamyl alcohol |
CHEMBL118958
CHEMBL324794 |
4 / 2 / 1 | No. 2320 | No. 6 |
![]() |
||
C00033349
![]() |
Sachalinoside A
/ (-)-Sachalinoside A |
No. 3482 |
![]() |
|||||
C00033346
![]() |
Sachalinol A
|
No. 4476 |
![]() |
|||||
C00033348
![]() |
Sachalinol C
/ (+)-Sachalinol C |
No. 5085 |
![]() |
|||||
C00033347
![]() |
Sachalinol B
/ (+)-Sachalinol B |
No. 5085 |
![]() |
|||||
C00033350
![]() |
Sachalinoside B
/ (-)-Sachalinoside B |
No. 8111 |
![]() |
|||||
C00031259
![]() |
Sachalol
|
No. 8174 |
![]() |
|||||
C00031187
![]() |
Rosiridoside A
/ (-)-Rosiridoside A |
No. 8654 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000615 C00000674 C00000960 C00002486 C00002647 C00002933 C00004565 C00008818 | 2 / 2 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000615 C00000674 C00000960 C00002647 C00002933 C00004565 C00008818 | 4 / 3 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000615 C00000674 C00000960 C00002647 C00002933 C00004565 C00008818 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000615 C00000674 C00000960 C00002647 C00002933 C00004565 C00008818 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000615 C00000674 C00000960 C00002486 C00002647 C00004565 C00008818 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000152 C00000580 C00000615 C00000674 C00002647 C00004565 C00008818 | 0 / 3 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000615 C00000674 C00004565 C00008818 C00031185 C00032375 | 1 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000615 C00000674 C00000960 C00002647 C00004565 C00008818 | 3 / 3 |
P03372 | Estrogen receptor | NR3A1 | C00000152 C00000580 C00000615 C00000674 C00002647 C00004565 | 1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000615 C00000674 C00002647 C00002933 C00004565 C00008818 | 1 / 1 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000152 C00000580 C00000615 C00002647 C00029515 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000615 C00000674 C00004565 C00008818 C00031274 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000615 C00000674 C00002486 C00002647 C00002933 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00000152 C00000580 C00000615 C00000674 C00004565 | 4 / 2 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000615 C00000674 C00000960 C00002647 C00008818 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000615 C00000674 C00002647 C00002933 C00004565 | 11 / 10 |
P15121 | Aldose reductase | Enzyme | C00000152 C00000580 C00000615 C00002647 C00004565 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000674 C00000960 C00002486 C00002933 C00031274 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000152 C00000580 C00000615 C00002647 C00029515 | 1 / 2 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000615 C00000674 C00000960 C00002647 C00029515 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000615 C00000674 C00000960 C00002486 C00002933 | 1 / 1 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000152 C00000580 C00000615 C00002647 C00029515 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000152 C00000580 C00000615 C00002647 C00029515 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000152 C00000580 C00000615 C00002647 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000674 C00000960 C00002933 C00008818 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00000615 C00000674 C00000960 C00002933 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000615 C00000674 C00002933 C00004565 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000152 C00000580 C00000615 C00002647 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000674 C00000960 C00002486 C00004565 | 1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000152 C00000580 C00000615 C00004565 | 1 / 8 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000674 C00000960 C00004565 C00008818 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000152 C00000580 C00000615 C00002647 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000615 C00000674 C00000960 C00004565 | 0 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000152 C00000580 C00000615 C00002647 | 1 / 2 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000152 C00000580 C00000615 C00002647 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00000674 C00000960 C00002486 C00004565 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000152 C00000580 C00000615 C00002647 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000615 C00000674 C00002933 C00004565 | 2 / 5 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000674 C00000960 C00002647 C00004565 | 7 / 37 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000152 C00000580 C00000615 C00002647 | 0 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000615 C00000960 C00002647 C00002933 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00000615 C00000674 C00000960 C00004565 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000615 C00000674 C00000960 C00004565 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000152 C00000580 C00000615 C00002647 | 3 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00000674 C00000960 C00004565 | 0 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000152 C00000580 C00000615 | 1 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000674 C00002647 C00004565 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00000674 C00000960 C00004565 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00000674 C00002933 C00008818 | 1 / 4 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00000674 C00002933 C00008818 | 0 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000615 C00000674 C00002933 | 3 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000615 C00000674 C00004565 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000615 C00000674 C00004565 | 0 / 1 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000152 C00000580 C00000615 | 0 / 0 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000152 C00000580 C00000615 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00000674 C00000960 C00004565 | 1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000615 C00000674 C00004565 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000674 C00004565 C00008818 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00000674 C00002933 C00004565 | 6 / 4 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000674 C00002647 C00004565 | 0 / 1 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000152 C00000580 C00000615 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00000674 C00000960 C00004565 | 4 / 4 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00000152 C00000580 C00000615 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00000674 C00000960 C00004565 | 1 / 1 |
P06280 | Alpha-galactosidase A | Enzyme | C00000615 C00000674 C00002486 | 1 / 1 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000615 C00000674 C00002933 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000674 C00002647 C00002933 | 4 / 1 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000152 C00000580 C00000615 | 1 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00002647 C00008818 C00029515 | 2 / 3 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00000674 C00000960 C00004565 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000615 C00000674 C00004565 | 1 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00000674 C00004565 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00000674 C00004565 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000674 C00004565 | 3 / 4 |
P11473 | Vitamin D3 receptor | NR1I1 | C00002647 C00008818 | 2 / 3 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00000674 C00004565 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00000674 C00002933 | 1 / 2 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00000674 C00004565 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00000674 C00004565 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00000674 C00004565 | 1 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002647 C00002933 | 0 / 0 |
Q05513 | Protein kinase C zeta type | Iota | C00002933 C00032577 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00002933 C00032577 | 0 / 1 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00000674 C00004565 | 0 / 0 |
Q02156 | Protein kinase C epsilon type | Eta | C00002933 C00032577 | 0 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00000674 C00004565 | 1 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00002933 C00032577 | 0 / 0 |
P56817 | Beta-secretase 1 | A1A | C00002933 C00008818 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002933 C00032577 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000615 C00000674 | 3 / 2 |
Q05655 | Protein kinase C delta type | Delta | C00002933 C00032577 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00002933 C00032577 | 1 / 1 |
P05771 | Protein kinase C beta type | Alpha | C00002933 C00032577 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00002933 C00032577 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00000615 C00000674 | 0 / 1 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000615 C00000674 | 2 / 2 |
P41743 | Protein kinase C iota type | Iota | C00002933 C00032577 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00002933 C00032577 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002486 C00002933 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00000674 C00004565 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00000674 C00004565 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00000674 C00000960 | 0 / 0 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00000615 C00002933 | 4 / 2 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000615 C00004565 | 2 / 2 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00000674 C00004565 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000615 C00004565 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00000674 C00004565 | 2 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00000674 C00004565 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00000674 C00004565 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00000674 C00004565 | 1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | C00000674 C00004565 | 0 / 0 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00000674 C00004565 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00000674 C00002933 | 2 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00000615 C00000674 | 1 / 3 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00000674 C00004565 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000615 C00002933 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00000674 C00004565 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00000674 C00002486 | 1 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00000674 C00000960 | 2 / 1 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000960 | 0 / 1 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00000615 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00004565 | 0 / 0 |
P45452 | Collagenase 3 | M10A | C00000674 | 1 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00004565 | 5 / 3 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00032375 | 1 / 0 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00002933 | 5 / 4 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00031274 | 0 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000615 | 5 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00004565 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000674 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00032375 | 0 / 0 |
Q9H2K2 | Tankyrase-2 | Enzyme | C00000674 | 0 / 0 |
O14763 | Tumor necrosis factor receptor superfamily member 10B | Unclassified protein | C00000674 | 1 / 0 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00008818 | 1 / 1 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000960 | 3 / 1 |
P12821 | Angiotensin-converting enzyme | M2 | C00002647 | 4 / 2 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000960 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00008818 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000615 | 0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
P14151 | L-selectin | Adhesion | C00002647 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002647 | 1 / 0 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00000674 | 0 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 | 0 / 1 |
P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 | 1 / 1 |
P10145 | Interleukin-8 | Secreted protein | C00002647 | 0 / 0 |
P00742 | Coagulation factor X | S1A | C00002933 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00008818 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00000674 | 4 / 2 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00032375 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002647 | 5 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000674 | 2 / 0 |
P42858 | Huntingtin | Unclassified protein | C00002933 | 1 / 1 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002486 | 2 / 2 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00004565 | 0 / 0 |
P16581 | E-selectin | Adhesion | C00002647 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000674 | 0 / 1 |
P17706 | Tyrosine-protein phosphatase non-receptor type 2 | Tyr | C00002933 | 0 / 1 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00008818 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00000674 | 1 / 0 |
P48147 | Prolyl endopeptidase | S9A | C00004565 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00000674 | 0 / 0 |
Q12794 | Hyaluronidase-1 | Enzyme | C00000615 | 1 / 2 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00008818 | 0 / 7 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00000615 | 0 / 0 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00000674 | 0 / 0 |
P51570 | Galactokinase | Enzyme | C00000674 | 1 / 1 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00000615 | 1 / 1 |
P10586 | Receptor-type tyrosine-protein phosphatase F | Receptor tyrosine-protein phosphatase | C00002933 | 0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00000674 | 0 / 0 |
P49327 | Fatty acid synthase | Transferase | C00000674 | 0 / 0 |
P78536 | Disintegrin and metalloproteinase domain-containing protein 17 | M12B | C00002647 | 1 / 0 |
P03951 | Coagulation factor XI | S1A | C00002933 | 1 / 1 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00000615 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00008818 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000674 | 1 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00004565 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002933 | 0 / 0 |
O95271 | Tankyrase-1 | Enzyme | C00000674 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000674 | 0 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00000674 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00004565 | 0 / 0 |
P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | C00008818 | 0 / 0 |
P39900 | Macrophage metalloelastase | M10A | C00000674 | 0 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002647 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00000674 | 0 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | C00000960 | 0 / 0 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00000615 | 0 / 0 |
P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | C00000615 | 0 / 0 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00002933 | 0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00004565 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00004565 | 0 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | C00000674 | 2 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000152
C00000674
C00002647
C00004565
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000674
C00002647
C00002933
C00004565
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000674
C00002933
C00004565
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000674
C00002647
C00004565
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000674
C00002647
C00004565
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000674
C00002647
C00004565
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00000674
C00000960
C00004565
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000674
C00002647
C00004565
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000674
C00002647
C00002933
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000674
C00002647
C00004565
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000152
C00000674
C00004565
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000674
C00002647
C00004565
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000674
C00002647
C00004565
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000152
C00002647
|
891 | CCNB1, CCNB | cyclin B1 |
C00000674
C00004565
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000674
C00004565
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000674
C00004565
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00000674
C00004565
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00000674
C00002647
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00002647
C00004565
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000674
C00002647
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00000674
C00004565
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000674
C00002647
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002647
C00004565
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00000674
C00004565
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000152
C00004565
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000674
C00004565
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000674
C00002647
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000674
C00004565
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00000674
C00002647
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000674
C00004565
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000674
C00004565
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00000674
C00004565
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000674
C00004565
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00000674
C00004565
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000674
C00002933
|
4793 | NFKBIB, IKBB, TRIP9 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
C00000674
C00002647
|
29110 | TBK1, NAK, T2K | TANK-binding kinase 1 (EC:2.7.11.1) |
C00000674
C00000960
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000960
C00004565
|
8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00000674
C00004565
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00000674
C00004565
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000674
C00004565
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00002647
C00004565
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000674
C00004565
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00000674
C00004565
|
7161 | TP73, P73 | tumor protein p73 |
C00000674
C00004565
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002647
C00004565
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000674
C00004565
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00000674
C00004565
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00000674
C00002647
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00000674
C00002647
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00000674
C00004565
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002647
C00004565
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000674
C00004565
|
2810 | SFN, YWHAS | stratifin |
C00000674
C00004565
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002647
C00004565
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000960
C00004565
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00000674
C00004565
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00000674
C00004565
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002647
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00004565
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00004565
|
8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00004565
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004565
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00004565
|
4502 | MT2A, MT2 | metallothionein 2A |
C00004565
|
110357 |
C00004565
|
||
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00004565
|
4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00004565
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00004565
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00004565
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00004565
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00004565
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00004565
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00004565
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000960
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00004565
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002933
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00004565
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000152
|
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00000152
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00002647
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00002647
|
545 | ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1 | ataxia telangiectasia and Rad3 related (EC:2.7.11.1) |
C00002647
|
613 | BCR, ALL, BCR1, CML, D22S11, D22S662, PHL | breakpoint cluster region (EC:2.7.11.1) |
C00002647
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
|
898 | CCNE1, CCNE | cyclin E1 |
C00002647
|
998 | CDC42, CDC42Hs, G25K | cell division cycle 42 |
C00002647
|
37618 |
C00004565
|
||
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002647
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002647
|
2551 | GABPA, E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A, RCH04A07 | GA binding protein transcription factor, alpha subunit 60kDa |
C00002647
|
2885 | GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2 | growth factor receptor-bound protein 2 |
C00002647
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00002647
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002647
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002647
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00002647
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00004565
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00004565
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00002647
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002647
|
4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00002647
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00004565
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00004565
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002647
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00002647
|
19412 |
C00002647
|
||
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00002647
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00002647
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00002647
|
9252 | RPS6KA5, MSK1, MSPK1, RLPK | ribosomal protein S6 kinase, 90kDa, polypeptide 5 (EC:2.7.11.1) |
C00002647
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002647
|
7224 | TRPC5, TRP5 | transient receptor potential cation channel, subfamily C, member 5 |
C00002647
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00004565
|
239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00000674
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000674
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00000674
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00000674
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000674
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00000674
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00000674
|
972 | CD74, DHLAG, HLADG, II, Ia-GAMMA | CD74 molecule, major histocompatibility complex, class II invariant chain |
C00000674
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00000674
|
1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00000674
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00000674
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00000674
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00000674
|
2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00000674
|
3726 | JUNB, AP-1 | jun B proto-oncogene |
C00000674
|
3727 | JUND, AP-1 | jun D proto-oncogene |
C00000674
|
5602 | MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK | mitogen-activated protein kinase 10 (EC:2.7.11.24) |
C00000674
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00000674
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000674
|
9572 | NR1D1, EAR1, THRA1, THRAL, ear-1, hRev | nuclear receptor subfamily 1, group D, member 1 |
C00000674
|
5347 | PLK1, PLK, STPK13 | polo-like kinase 1 (EC:2.7.11.21) |
C00000674
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00000674
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000674
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000674
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00000674
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000674
|
10451 | VAV3 | vav 3 guanine nucleotide exchange factor |
C00000674
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#600807 | Asthma, susceptibility to |
Q13093
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P18054
P84022 Q14191 |
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#218800 | Crigler-najjar syndrome, type i |
P22309
|
#606785 | Crigler-najjar syndrome, type ii |
P22309
|
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#227600 | Factor x deficiency |
P00742
|
#612416 | Factor xi deficiency |
P03951
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#230200 | Galactokinase deficiency |
P51570
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#143500 | Gilbert syndrome |
P22309
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#614519 | Hemorrhage, intracerebral, susceptibility to; ich |
P12821
|
#114550 | Hepatocellular carcinoma |
P08581
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#614328 | Inflammatory skin and bowel disease, neonatal; nisbd |
P78536
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04637 |
#300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#612624 | Microvascular complications of diabetes, susceptibility to, 3; mvcd3 |
P12821
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#601665 | Obesity |
P37231
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#267430 | Renal tubular dysgenesis; rtd |
P12821
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
O14763
P04637 |
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601367 | Stroke, ischemic |
P12821
P16109 P24723 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) P08581 (related) P10415 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04637 (related) P08253 (related) P10415 (related) |
H00030 | Cervical cancer |
P00533
(related)
P10415 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) Q15046 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) |
H00938 | Factor XI deficiency |
P03951
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P10415 (related) P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
P10415 (related) |
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
P10415 (related) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P08581 (related) P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00083 | Allograft rejection |
P12821
(related)
|
H00575 | Renal tubular dysgenesis |
P12821
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00408 | Type I diabetes mellitus |
P17706
(related)
Q04759 (related) |
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00070 | Galactosemia |
P51570
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D009202 | Cardiomyopathies |
C00004565
C00000674 |
D006943 | Hyperglycemia |
C00004565
C00002647 |
D006949 | Hyperlipidemias |
C00002647
|
D002318 | Cardiovascular Diseases |
C00004565
|
D001943 | Breast Neoplasms |
C00004565
|
D007938 | Leukemia |
C00004565
|
D010024 | Osteoporosis |
C00004565
|
D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
D008545 | Melanoma |
C00000152
|
D003921 | Diabetes Mellitus, Experimental |
C00002647
|
D050171 | Dyslipidemias |
C00002647
|
D005234 | Fatty Liver |
C00002647
|
D018149 | Glucose Intolerance |
C00002647
|
D006937 | Hypercholesterolemia |
C00002647
|
D050197 | Atherosclerosis |
C00004565
|
D015228 | Hypertriglyceridemia |
C00002647
|
D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
C00002647
|
D008546 | Melanoma, Experimental |
C00002647
|
D009069 | Movement Disorders |
C00002647
|
D009203 | Myocardial Infarction |
C00002647
|
D009361 | Neoplasm Invasiveness |
C00002647
|
D009362 | Neoplasm Metastasis |
C00002647
|
D012516 | Osteosarcoma |
C00002647
|
D010182 | Pancreatic Diseases |
C00002647
|
D002386 | Cataract |
C00000674
|
D005483 | Flushing |
C00000674
|
D006529 | Hepatomegaly |
C00000674
|
D008103 | Liver Cirrhosis |
C00000674
|
D010051 | Ovarian Neoplasms |
C00000674
|